Do patients with rheumatoid arthritis report symptom improvement within the first week of adalimumab treatment?
Direct evidence regarding symptom improvement within the first week of adalimumab treatment in rheumatoid arthritis patients is lacking. Broader evidence suggests substantial clinical improvements within 12 weeks, but early effects within the first seven days specifically require further investigation.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-10-30
- DOI
- https://doi.org/10.5281/zenodo.23814696
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00